Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents | Zendy

Roberto Canitano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents

Author(s) -

Roberto Canitano

Publication year - 2008

Publication title -

neuropsychiatric disease and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.819

H-Index - 67

eISSN - 1178-2021

pISSN - 1176-6328

DOI - 10.2147/ndt.s1450

Subject(s) - risperidone , medicine , autism , psychiatry , clinical trial , autistic spectrum , pharmacotherapy , autism spectrum disorder , clinical psychology , pediatrics , schizophrenia (object oriented programming)

This is a review of the clinical trials investigating the efficacy and safety of risperidone in the treatment of children with autistic spectrum disorders (ASD). The main clinical characteristics are impairment in social skills, communication difficulties, repetitive movements and behaviors, including stereotypies. Pharmacotherapy is mainly directed at the so-called target symptoms, ie, behavioral disorders and the various kinds of repetitions associated with ASD. According to the available data, risperidone seems to be moderately efficacious and safe for treating behavioral disorders. 4 double blind controlled trial. 3 reanalysis studies, and 12 open studies have documented the role of risperidone in children with ASD. Controlled studies have been thoroughly considered in this review.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research